Print this page    •   Back to Web version of article

International News
Trade Agreements Could Harm Access to Antiretroviral Drugs in Asia, Pacific, Experts and Activists Warn

July 13, 2012

"Pressure on developing countries to adopt clauses affecting intellectual property rights could limit access to generic antiretroviral (ARV) drugs in Asia and the Pacific, experts and activists warn," PlusNews reports. According to Steven Kraus, director of the UNAIDS program in Asia and the Pacific region, only about one-third of the people in need of treatment in the region receive it, and the long-term sustainability of even that proportion will be challenging in the current economic climate, the news service notes. Kraus said World Trade Organization (WTO) member states should take advantage of flexibilities under the Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement to manufacture and procure generic versions of medications "to ensure sustainability and the significant scale-up of HIV services to reach people most in need," PlusNews continues.

"However, bilateral and regional Free Trade Agreements (FTAs) and Economic Partnership Agreements could contain clauses that undermine the TRIPS flexibilities, such as extending the life of patents beyond 20 years," the news service states and discusses the Trans-Pacific Partnership Trade Agreement (TPP) currently under negotiation in the region. Activists say the TPP -- a multilateral trade agreement among Singapore, Malaysia, Vietnam, Brunei Darussalam, Australia, New Zealand, Chile, Peru, and the United States -- "will threaten access to generic medicines and are urging those countries still negotiating, such as Malaysia and Vietnam, not to join," according to PlusNews (7/12).

Back to other news for July 2012


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/67850/trade-agreements-could-harm-access-to-antiretrovir.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.